Lowering Low-Density Lipoprotein Cholesterol Concentration with Plant Stanol Esters to Reduce the Risk of Atherosclerotic Cardiovascular Disease Events at a Population Level: A Critical Discussion

Lowering Low-Density Lipoprotein Cholesterol Concentration with Plant Stanol Esters to Reduce the Risk of Atherosclerotic Cardiovascular Disease Events at a Population Level: A Critical Discussion

Atherosclerotic cardiovascular diseases (ASCVDs) cause every fifth death worldwide. However, it is possible to prevent the progression of ASCVDs by reducing circulating concentrations of low-density lipoprotein cholesterol (LDL-C). Recent large meta-analyses demonstrated that by reducing the dietary...

Full description

Bibliographic Details
Main Authors:	Helena Gylling, Timo E. Strandberg, Petri T. Kovanen, Piia Simonen
Format:	Article
Language:	English
Published:	MDPI AG 2020-08-01
Series:	Nutrients
Subjects:	atherosclerosis cardiovascular disease cholesterol lipoprotein nutrition plant stanol
Online Access:	https://www.mdpi.com/2072-6643/12/8/2346

Similar Items

Dose-dependent LDL-cholesterol lowering effect by plant stanol ester consumption: clinical evidence
by: Laitinen Kirsi, et al.
Published: (2012-10-01)

Cholesterol lowering efficacy of plant stanol ester in a new type of product matrix, a chewable dietary supplement
by: Kirsi Laitinen, et al.
Published: (2017-03-01)

Obesity Does Not Interfere with the Cholesterol-Lowering Effect of Plant Stanol Ester Consumption (as Part of a Heart-Healthy Diet)
by: Piia Simonen, et al.
Published: (2021-04-01)

Plant stanol esters and blood cholesterol ‐ Scientific substantiation of a health claim related to plant stanol esters and lower/reduced blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006 ‐ Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies
by: European Food Safety Authority (EFSA)
Published: (2008-10-01)

Anti-Inflammatory Effects of Dietary Plant Stanol Supplementation Are Largely Dependent on the Intake of Cholesterol in a Mouse Model of Metabolic Inflammation
by: Inês Magro dos Reis, et al.
Published: (2021-05-01)

Plant Sterols and Plant Stanols in Cholesterol Management and Cardiovascular Prevention
by: Fotios Barkas, et al.
Published: (2023-06-01)

Scientific Opinion on the substantiation of a health claim related to the consumption of 2 g/day of plant stanols (as plant stanol esters) as part of a diet low in saturated fat and a two-fold greater reduction in blood LDL-cholesterol concentrations compared to the consumption of a diet low in saturated fat alone pursuant to Article 14 of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Published: (2013-04-01)

Randomized studies of «functional» foods enriched with plant sterols and stanols: efficiacy in correction of dyslipidemia
by: M. A. Khuchiyeva, et al.
Published: (2014-06-01)

Chemical and microbiological considerations of phytosterols and their relative efficacies in functional foods for the lowering of serum cholesterol levels in humans: A review
by: Alfred Wong
Published: (2014-01-01)

St Hubert Cholegram, une aide efficace dans la lutte contre le LDL-cholestérol
by: Breton Sylvie
Published: (2007-09-01)

Use of plant stanol ester margarine among persons with and without cardiovascular disease: Early phases of the adoption of a functional food in Finland
by: Boice John D, et al.
Published: (2005-06-01)

Plant Sterols and Stanols for Pediatric Patients with Increased Cardiovascular Risk
by: Cristina Pederiva, et al.
Published: (2024-01-01)

The Impacts of Cholesterol, Oxysterols, and Cholesterol Lowering Dietary Compounds on the Immune System
by: Rintaro Yanagisawa, et al.
Published: (2022-10-01)

High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and Atherosclerosis
by: Alice Ossoli, et al.
Published: (2016-06-01)

Correlation of Discordance between Remnant Lipoprotein Cholesterol and Non-high-density Lipoprotein Cholesterol and Severity of Coronary Stenosis
by: CHEN Yan, LYU Zhibo, ZHAO Xin
Published: (2023-08-01)

Serum sterols during stanol ester feeding in a mildly hypercholesterolemic population
by: H. Gylling, et al.
Published: (1999-04-01)

EFFECT OF DIETARY OLIVE OIL/CHOLESTEROL ON SERUM LIPOPROTEINS, LIPID PEROXIDATION, AND ATHEROSCLEROSIS IN RABBITS
by: R MAHDAVI, et al.
Published: (2003-03-01)

Impacts of human and herbivorous feces on lake surface sediments of the Tibetan Plateau based on fecal stanol proxies
by: Cunlin Li, et al.
Published: (2024-01-01)

Serum, but not monocyte macrophage foam cells derived from low HDL-C subjects, displays reduced cholesterol efflux capacity
by: Shuhei Nakanishi, et al.
Published: (2009-02-01)

MEDI6012: Recombinant Human Lecithin Cholesterol Acyltransferase, High‐Density Lipoprotein, and Low‐Density Lipoprotein Receptor–Mediated Reverse Cholesterol Transport
by: Richard T. George, et al.
Published: (2021-07-01)

Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment
by: Kexin Wang, et al.
Published: (2022-10-01)

Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum
by: Michael J. Wilkinson, et al.
Published: (2023-06-01)

Bile acid and cholesterol metabolism in atherosclerotic cardiovascular disease and therapy
by: John Y. L. Chiang, et al.
Published: (2020-01-01)

Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk
by: Francesco Baratta, et al.
Published: (2023-02-01)

Gene-diet interaction in plasma lipid response to plant sterols and stanols: A review of clinical trials
by: Mussa Makran, et al.
Published: (2021-12-01)

Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
by: Peter Willeit, et al.
Published: (2020-12-01)

Resveratrol protects against diet-induced atherosclerosis by reducing low-density lipoprotein cholesterol and inhibiting inflammation in apolipoprotein E-deficient mice
by: Geng-Ruei Chang, et al.
Published: (2015-11-01)

From intensive statins to intensive lipid lowering: Amplitude of low-density lipoprotein-cholesterol lowering is the core for atherosclerosis cardiovascular disease prevention
by: Daoquan Peng
Published: (2018-01-01)

Hyperabsorption and retention of campestanol in a sitosterolemic homozygote: comparison with her mother and three control subjects
by: Gerald Salen, et al.
Published: (2000-11-01)

Differential rate of cholesterol efflux from the apical and basolateral membranes of MDCK cells
by: A.T. Remaley, et al.
Published: (1998-06-01)

The early years of lipoprotein research: from discovery to clinical application
by: Patty W. Siri-Tarino, et al.
Published: (2016-10-01)

High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives
by: Maria Pia Adorni, et al.
Published: (2021-03-01)

Low High-Density Lipoprotein Cholesterol Predisposes to Coronary Artery Ectasia
by: Jamal Jafari, et al.
Published: (2019-10-01)

High-density lipoprotein cholesterol to low-density lipoprotein cholesterol ratio in early assessment of disease severity and outcome in patients with acute pancreatitis admitted to the ICU
by: Qin Wu, et al.
Published: (2020-05-01)

Comparison of soymilk and probiotic soymilk effects on serum high-density lipoprotein cholesterol and low-density lipoprotein cholesterol in diabetic Wistar rats
by: Mina Babashahi, et al.
Published: (2015-04-01)

Patients with familial hypercholesterolemia and COVID-19: Efficient and ongoing cholesterol lowering is paramount for the prevention of acute myocardial infarction
by: Petri T. Kovanen, et al.
Published: (2021-09-01)

Functionalized Periodic Mesoporous Silica Nanoparticles for Inhibiting the Progression of Atherosclerosis by Targeting Low-Density Lipoprotein Cholesterol
by: Hao Jin, et al.
Published: (2024-01-01)

Comparison of low-density lipoprotein cholesterol level calculated using the modified Martin/Hopkins estimation or the Friedewald formula with direct homogeneous assay measured low-density lipoprotein cholesterol
by: Istvan Reiber, et al.
Published: (2020-08-01)

The formation and consequences of cholesterol-rich deposits in atherosclerotic lesions
by: Frederick R. Maxfield, et al.
Published: (2023-02-01)

Association of cholesteryl ester transfer protein with HDL particles reduces its proteolytic inactivation by mast cell chymase
by: Miriam Lee-Rueckert, et al.
Published: (2008-02-01)